Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service

Jonathan G. Leung, Daniela B. Rakocevic, Nicholas D. Allen, Elliot M. Handler, Bruno A. Perossa, Kristin L. Borreggine, Amy L. Stark, Hannah K. Betcher, Daniel K. Hosker, Blaine A. Minton, Benjamin R. Braus, Ross A. Dierkhising, Kemuel L. Philbrick

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Background: Benzodiazepines are the conventional mainstay to manage alcohol withdrawal; however, patients are subsequently at increased risk for poor sleep, cravings, and return to drinking. Research on alternative pharmacologic agents to facilitate safe alcohol withdrawal is scant. Gabapentin is one medication shown in small studies to reduce the need for benzodiazepines in the setting of alcohol withdrawal. The continuation of gabapentin after alcohol withdrawal appears to be safe during early sobriety and may aid in reducing alcohol-related cravings or returning to alcohol consumption. Use of a gabapentin-based, benzodiazepine-sparing protool began in early 2015 by the Mayo Clinic, Rochester, Consultation-Liaison Psychiatry Service. Objective: A retrospective chart review was conducted to detect any safety concerns with use of a gabapentin protocol for alcohol withdrawal syndrome. Methods: Secondary outcomes were derived by comparing a matched cohort of patients who received benzodiazepines for alcohol withdrawal syndrome. Results: Seventy-seven patients had their alcohol withdrawal managed via a gabapentin protocol during the study period. No patients required transfer to a higher level of care or had a documented withdrawal seizure. Length of stay between the gabapentin protocol group and benzodiazepine group were similar. Conclusion: This preliminary data has supported the frequent use of this protocol in the general internal medicine practice and formalization of an institutional order set of this protocol for mild to moderate alcohol withdrawal syndrome. Prospective studies are required to validate findings.

Original languageEnglish (US)
Pages (from-to)496-505
Number of pages10
JournalPsychosomatics
Volume59
Issue number5
DOIs
StatePublished - Sep 1 2018

Bibliographical note

Funding Information:
Financial disclosure: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors of this paper have no sources of financial support or conflicts of interest relevant to this manuscript. Additional disclosure: Preliminary findings related to this manuscript have been submitted to the 66th Annual Meeting, Academy of Psychosomatic Medicine as an oral poster.

Publisher Copyright:
© 2018 Academy of Consultation-Liaison Psychiatry

Keywords

  • Alcohol
  • Alcohol withdrawal syndrome.
  • Craving
  • Dependence
  • Gabapentin
  • Withdrawal

Fingerprint

Dive into the research topics of 'Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service'. Together they form a unique fingerprint.

Cite this